DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Furuta H, Uemura T, Yoshida T. et al
Efficacy and safety data of osimertinib in elderly patients with NSCLC who harbor the EGFR T790M mutation after failure of initial EGFR-TKI treatment.
Anticancer Res 2018;
38 (09) 5231-5237
We do not assume any responsibility for the contents of the web pages of other providers.